Bladder Instillation Recalled for Lack of Sterility Assurance
Natures Pharmacy & Compounding Center is recalling all lots of Bladder Instillation due to quality control concerns affecting sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a lack of sterility assurance in a medical product, which aligns with the criteria for a Severe rating.
Plain-English summary
Natures Pharmacy & Compounding Center is recalling all lots of Bladder Instillation. The recall is due to concerns associated with quality control procedures that present a potential risk to sterility assurance, which were observed during a recent FDA inspection.
The recall includes all lots of sterile products compounded by the pharmacy that are not expired. The distribution pattern is listed as NC.
Consumers should stop using the product and contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- Bladder Instillation
- Manufacturer
- Natures Pharmacy & Compounding Center
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lot numbers within expiry.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 48 recalled by Natures Pharmacy & Compounding Center under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 48 products in this recall →Related recalls
Same manufacturer · Natures Pharmacy & Compounding Center
See all →- SevereNatures Pharmacy Recalls Triamcinolone Acetonide Due to Sterility Concerns
FDA (Drugs) · 2014-03-12
- SevereSodium Bicarbonate Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12
- SevereFDA Recalls Estradiol and Testosterone Compounds for Sterility Concerns
FDA (Drugs) · 2014-03-12
- SevereNatures Pharmacy Recalls Glutathione Inhalation Due to Sterility Concerns
FDA (Drugs) · 2014-03-12
- SevereNatures Pharmacy Recalls Voriconazole Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SeverePharmedium Recalls Fentanyl Citrate Injection Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- SevereProstaglandin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-04-24
- SevereB-Complex Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereAnderson Compounding Pharmacy Recalls Prostaglandin Tri-Mix Injection Due to Sterility Concerns
FDA (Drugs) · 2019-04-24
- SeverePharmedium Recalls Adenosine Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2018-02-28
- HighVerapamil Injection Is Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2013-08-21